Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs)

Clinical Nephrology

Volumn 69, Issue 3, 2008, Pages 213-218

  Aranda, P ^a   Valdivielso, P ^b   Pisciotta, L ^c   Garcia, J ^a   Garcia Arias C ^b   Bertolini, S ^c   Martin Reyes G ^a   Gonzalez Santos P ^b   Calandra, S ^d  

^a Hospital Carlos Haya

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Angiotensin II receptor blockers; LCAT deficiency; Multifactorial therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ATORVASTATIN; DOXAZOSIN; EZETIMIBE; GEMFIBROZIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PERINDOPRIL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PRAVASTATIN; TELMISARTAN; TORASEMIDE; VERAPAMIL;

ADULT; ARTICLE; BLOOD PRESSURE; CASE MANAGEMENT; CASE REPORT; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; DRUG MEGADOSE; DYSLIPIDEMIA; GENE MUTATION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIPOPROTEIN DEFICIENCY; MALE; PROTEINURIA;

EID: 40449092620     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP69213     Document Type: Article

References (20)